PPARGC1A and metabolic dysfunction-associated steatotic liver disease: The ability of PGC-1α to increase the expression of mitochondrial genes while also increasing the expression of gluconeogenic genes may therefore seem to have contrasting effects on the pathogenesis of NAFLD.